Landy J and Hart AL |
Commentary: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336680
|
Hirai F et al. |
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336690
|
Schmidt KJ et al. |
Letter: short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - authors' reply. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23336691
|
Baumgart DC et al. |
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease. |
2003 |
Aliment. Pharmacol. Ther. |
pmid:12755840
|
Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Yamamoto T et al. |
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:26762838
|
Ierardi E et al. |
Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11207512
|
Schmidt KJ et al. |
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23121200
|
Romano C et al. |
Oral tacrolimus (FK 506) in refractory paediatric ulcerative colitis. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20148798
|
Yamamoto S et al. |
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18549460
|
O'Leary JG |
Editorial: tacrolimus-how low can you go? |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589579
|
Beckebaum S et al. |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. |
2009 |
Aliment. Pharmacol. Ther. |
pmid:19624550
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Hisanaga Y et al. |
Implication of nitric oxide synthase activity in the genesis of water immersion stress-induced gastric lesions in rats: the protective effects of FK506. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971291
|
Schwrer H et al. |
Pantoprazole and cyclosporine or tacrolimus. |
2001 |
Aliment. Pharmacol. Ther. |
pmid:11284790
|
Mehta SJ et al. |
Review article: strategies for the management of chronic unremitting ulcerative colitis. |
2013 |
Aliment. Pharmacol. Ther. |
pmid:23718288
|
Yamamoto T et al. |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040167
|
Taylor KM and Sparrow MP |
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis. |
2016 |
Aliment. Pharmacol. Ther. |
pmid:27040166
|
Nakase H et al. |
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20636704
|